Feeds:
Posts
Comments

Posts Tagged ‘Gloucester pharmaceuticals’

TODAY’S NEWS

Celgene to buy Gloucester Pharmaceuticals, another company with a focus on developing drugs for blood cancer. I really like Celgene’s laser-like focus in its product portfolio – very smart.

Keep those new blood thinners coming.

AstraZeneca‘s Seroquel gets an expanded label for Major Depressive Disorder (add-on treatment).

Folotyn: 30K/month cancer treatment?? Wow (from NY Times).

The race for the new oral MS drug approval – did Novartis just take the lead?

RECOMMENDED

Medical Device Training. The Impactiviti network of providers has what you need.  Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.

PLUS

Pharma: Socializing in a Straitjacket? A somewhat shallow brushstroke in AdWeek about pharma and social media. AND – only TWO FDA inspectors in all of China (where much drug manufacturing is moving)? I bet that gets changed fast!

JUST FOR FUN

Will a young dog remember a family member who has been gone for 3 months? Watch and see!

———-

Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)

Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)

Connect with Steve Woodruff

Read Full Post »